Anxo Pharmaceutical Co., Ltd. (TPEX:6677)

Anxo Pharmaceutical Revenue

Anxo Pharmaceutical had revenue of 402.78M TWD in the half year ending June 30, 2025, a decrease of -9.53%. This brings the company's revenue in the last twelve months to 883.22M, down -2.90% year-over-year. In the year 2024, Anxo Pharmaceutical had annual revenue of 895.32M, down -4.75%.

• Revenue (ttm): 883.22M
• Revenue Growth: -2.90%
• P/S Ratio: 1.27
• Revenue / Employee: n/a
• Employees: 307
• Market Cap: 1.12B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	895.32M	-44.62M	-4.75%
Dec 31, 2023	939.94M	73.67M	8.50%
Dec 31, 2022	866.27M	42.17M	5.12%
Dec 31, 2021	824.10M	-42.01M	-4.85%
Dec 31, 2020	866.11M	-11.82M	-1.35%